Lung Cancer and Personalized Medicine : Novel Therapies and Clinical Management / edited by Aamir Ahmad, Shirish M Gadgeel
Contributor(s): Ahmad, Aamir, editor literario
| Gadgeel, Shirish M., editor literario | SpringerLink (Online service)
Material type: 
E-bookSeries: (Advances in Experimental Medicine and Biology, 0065-2598; 890).Publisher: Cham : Springer International Publishing, 2016Edition: 1st ed.Description: 1 recurso en línea (X, 231 páginas) : 22 ilustraciones, 1 ilustraciones en color.ISBN: 9783319249322.Subject: Pulmones -- Cáncer | Cáncer -- Investigación | Ciencias biomédicasDDC classification: 614.5999 Online resources: Acceso a este recurso digital (usuarios Universidad Europea de Madrid)
Summary: This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.�.
| Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RC280.L8 L862 2016 EB (Browse shelf(Opens below)) | .i11613191 | Acceso electrónico | eBOOK .i11613191 |
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality.�.
There are no comments on this title.